Current status of the only approved treatment for AD:
Some hailed Aduhelm as the first new medication for Alzheimer's disease in decades. But many others questioned Aduhelm's safety and effectiveness, and Medicare refused to cover the drug's high cost because of doubt over its effectiveness.
Jan 31, 2024 https://www.usnews.com › articles Biogen Is Dropping Controversial Alzheimer's Drug Aduhelm.
Many researchers, believe that Amyloid beta or Tau proteins are components of the brain’s immune system. If any of the companies you selected are attempting to remove amyloid beta, or tau, I can personally guarantee you those companies will fail miserably.
Do a Google search for: Pubmed herpes and AD
This will give you two decades worth of peer reviewed research showing there’s definitely a link between herpes and AD.
AD is seen about six decades after the initial untreated, viral infection. …. Just like shingles onset is about 40 years after a chickenpox infection.
Good luck!
However, you could probably do much better going after the global pandemic for obesity. Either or both of NVO and LLY are going to see decades of growth for Ozempic And Moungero.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.